SCHEMBL10356325

SCHEMBL10356325

CCCCCOc1ccccc1C#N

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.56
HPGD P15428 2/20 0.56
CYP1A2 P05177 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
ADRA2A P08913 2/20 0.47
HTR2B P41595 2/20 0.47
MEN1 O00255 1/20 0.47
NR1I2 O75469 1/20 0.47
LMNA P02545 1/20 0.47
CHRM2 P08172 1/20 0.47
CYP3A4 P08684 1/20 0.47
MAPT P10636 1/20 0.47
OPRK1 P41145 1/20 0.47
SLC6A3 Q01959 1/20 0.47
KMT2A Q03164 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
MAPK1 P28482 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30631552 0.98 ALDH1A1 (0.58) ALDH1A1HPGDCYP1A2CYP2C9CYP2C19
SCHEMBL16188206 0.98 ALDH1A1 (0.58) ALDH1A1HPGDCYP1A2CYP2C9CYP2C19
SCHEMBL3145001 0.98 ALDH1A1 (0.58) ALDH1A1HPGDCYP1A2CYP2C9CYP2C19
SCHEMBL15541094 0.98 ALDH1A1 (0.58) ALDH1A1HPGDCYP1A2CYP2C9CYP2C19
SCHEMBL2975924 0.98 ALDH1A1 (0.58) ALDH1A1HPGDCYP1A2CYP2C9CYP2C19
SCHEMBL6958088 0.98 ALDH1A1 (0.58) ALDH1A1HPGDCYP1A2CYP2C9CYP2C19
SCHEMBL1444254 0.95 CYP1A2 (0.55) ALDH1A1HPGDCYP1A2CYP2C9CYP2C19
SCHEMBL973234 0.89 ALDH1A1 (0.54) ALDH1A1HPGDCYP1A2CYP2C9CYP2C19
Hydrochloric Acid SCHEMBL13857771 0.87 ALDH1A1 (0.53) ALDH1A1HPGDCYP1A2CYP2C9CYP2C19
SCHEMBL9808371 0.87 ALDH1A1 (0.48) ALDH1A1HPGDCYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120184565-A1 COMPOUNDS FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION BRISTOL-MYERS SQUIBB COMPANY 2012-07-19 US disclosed
CN-1980905-B An improved process for preparing n-hydroxy-4-{5- [4- (5-isopropyl-2-methyl-l, 3-thiazol-4-yl) -phenoxy] -pentoxy }-benzamidine DONG WHA PHARM IND CO LTD 2010-04-21 CN disclosed
CN-100562252-C A kind of herbicidal composition SINOCHEM CORP SHENYANG RES I O (CN) 2009-11-25 CN disclosed
CN-101433205-A Herbicide composition SINOCHEM CORP (CN) 2009-05-20 CN disclosed
EP-1827427-B1 ARYLOXYETHYLAMINE DERIVATIVES WITH A COMBINATION OF PARTIAL DOPAMINE-D2 RECEPTOR AGONISM AND SEROTONIN REUPTAKE INHIBITION SOLVAY PHARM BV (NL) 2008-07-23 EP disclosed
CN-101010308-A Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition comprising the same DONG WHA PHARM IND CO LTD (KR) 2007-08-01 CN disclosed
CN-1980905-A An improved process for preparing n-hydroxy-4-{5- [4- (5-isopropyl-2-methyl-l, 3-thiazol-4-yl) -phenoxy] -pentoxy }-benzamidine DONG WHA PHARM IND CO LTD (KR) 2007-06-13 CN disclosed
CN-1105163-C Liquid crystal compounds, mixtures and devices SECR DEFENCE (GB) 2003-04-09 CN disclosed
CN-1143382-A Liquid crystal compounds, mixtures and devices SECR DEFENCE (GB) 1997-02-19 CN disclosed
CN-1009152-B Herbicidal compositions containing N- [ (4, 6-dimethoxypyrimidin-2-yl) aminocarbonyl ] -3-trifluoromethylpyridine-2-sulfonamide or salts thereof ISHIHARA SANGYO KAISHA (JP) 1990-08-15 CN disclosed
CN-85109761-A N-[(4,6-dimethoxypyridin-2-yl) aminocarboxyl]-production method of 3-5-flumethiazine-2-sulfanilamide (SN) and salt thereof, and the pesticide composition that contains it 1986-12-17 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120184565-A1 COMPOUNDS FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION APP, BACE1, IAPP ALDH1A1 1538/4885HPGD 793/4885CYP1A2 1278/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.